A young man with biventricular dysfunction and severe malperfusion to multiple organs is put on ECMO and Impella support. Despite Impella malfunction and subsequent stroke, he recovered to undergo heart-kidney transplant.
If the findings of a new retrospective study are confirmed in a randomized controlled trial, phosphodiesterase-5 inhibitors could become standard of care in this setting.
Our heart surgeons share advice on how to avoid postcardiotomy shock and help ensure success with coronary bypass in patients with left ventricular failure due to ischemic cardiomyopathy.
Enthusiasm for the use of temporary hemodynamic support must be tempered by the lack of randomized evidence of a mortality benefit in this setting.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A new JACC statement makes the case for earlier referral of patients with advanced heart failure. Our experts review the recommendations and the rationale behind them.
ECMO and other forms of mechanical circulatory support have a role in cases involving either respiratory failure or cardiac failure, but generally not both. An expert surgeon reviews management strategies.
The national PI of the ROADMAP trial shares his passion for VADs, current research projects that excite him and why he made a mid-career move to Cleveland Clinic.
Our experts share eight trends and developments that excite them most in mechanical circulatory support and beyond.
As the use of LVADs for destination therapy grows, a new study offers the first guidance on whether aggressive treatment for atrial arrhythmias makes a difference in this setting.